ENTA icon

Enanta Pharmaceuticals
ENTA

Overview Fund Activity

54 hedge funds and large institutions have $87.3M invested in Enanta Pharmaceuticals in 2013 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 17 increasing their positions, 13 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
54
Holders Change
+12
Holders Change %
+28.57%
% of All Funds
1.75%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
18
Increased
17
Reduced
13
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
CCM
1
Consonance Capital Management
New York
$13.1M
2
B
2
Bailard
California
$2.99M
3
SCM
3
Sigma Capital Management
Connecticut
$1.83M
4
BIM
4
Bogle Investment Management
Massachusetts
$1.23M
5
Franklin Resources
5
Franklin Resources
California
$12.2M

Top Sellers

1
RCM
1
RA Capital Management
Massachusetts
$0
2
BI
2
BVF Inc
California
$0
3
BIT
3
BlackRock Institutional Trust
California
$1.88M
4
BA
4
BlackRock Advisors
Delaware
$45K
5
Morgan Stanley
5
Morgan Stanley
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Creative Planning
51
Creative Planning
Kansas
$12K +$12K +542 New
Bank of America
52
Bank of America
North Carolina
$1K -$187K -4,849 -99%
RCM
53
RA Capital Management
Massachusetts
– -$7.72M -436,145 Closed
BI
54
BVF Inc
California
– -$2.72M -153,500 Closed
Morgan Stanley
55
Morgan Stanley
New York
– -$773K -43,678 Closed
FCH
56
Freestone Capital Holdings
Washington
– -$358K -20,200 Closed
SSG
57
Summit Securities Group
New York
– -$18K -1,000 Closed
Manulife (Manufacturers Life Insurance)
58
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$2K -128 Closed
1 2
3